Not much activity being pushed to the National Library of Medicine, at least nothing since April...
But the study isn't due to complete until the end of next year of beginning of 2025.
Link: A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy
- Forums
- ASX - By Stock
- IMU
- IMU product line - PD1-Vaxx
IMU
imugene limited
Add to My Watchlist
7.69%
!
1.4¢

IMU product line - PD1-Vaxx, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $104.5M |
Open | High | Low | Value | Volume |
1.3¢ | 1.4¢ | 1.2¢ | $134.2K | 10.31M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1168170 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 9464131 | 33 |
Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
Day chart unavailable